Predict anticancer efficacy with a new *in vitro* 3D modeling platform

Watch this presentation by Dr. Kolin Hribar, Founder and CEO, Cypre, and Dr. Julia Schueler, Research Director, Charles River Laboratories, titled: Predict anticancer efficacy with a new in vitro 3D modeling platform. This talk was presented at the SelectScience^® Virtual Cancer and Immunology Research Summit 2021.